Expression and NMR Structural Studies of Isotopically Labeled Cannabinoid Receptor Type II.

[1]  W. Guba,et al.  Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases , 2016, ChemMedChem.

[2]  M. Pitman,et al.  Global Fold of Human Cannabinoid Type 2 Receptor Probed by Solid-State NMR and Molecular Dynamics Simulations , 2015 .

[3]  Ming Li,et al.  (2) Protein structure determination on demand , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.

[4]  K. Gawrisch,et al.  Stabilization of Functional Recombinant Cannabinoid Receptor CB2 in Detergent Micelles and Lipid Bilayers , 2012, PloS one.

[5]  K. Rice,et al.  Recombinant Cannabinoid Type 2 Receptor in Liposome Model Activates G Protein in Response to Anionic Lipid Constituents* , 2011, The Journal of Biological Chemistry.

[6]  P Pacher,et al.  Is lipid signaling through cannabinoid 2 receptors part of a protective system? , 2011, Progress in lipid research.

[7]  K. Gawrisch,et al.  Preparation of stable isotope-labeled peripheral cannabinoid receptor CB2 by bacterial fermentation. , 2010, Protein expression and purification.

[8]  G. Cabral,et al.  Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation , 2009, Expert Reviews in Molecular Medicine.

[9]  N. Stella,et al.  CB2 receptor‐mediated migration of immune cells: it can go either way , 2008, British journal of pharmacology.

[10]  K. Gawrisch,et al.  Use of dual affinity tags for expression and purification of functional peripheral cannabinoid receptor. , 2007, Protein expression and purification.

[11]  G. Velasco,et al.  Cannabinoid CB2 receptor: a new target for controlling neural cell survival? , 2007, Trends in pharmacological sciences.

[12]  K. Gawrisch,et al.  Expression of human peripheral cannabinoid receptor for structural studies , 2005, Protein science : a publication of the Protein Society.

[13]  A. Wand,et al.  Protein structure determination by high-resolution solid-state NMR spectroscopy: application to microcrystalline ubiquitin. , 2005, Journal of the American Chemical Society.

[14]  A. Barbáchano,et al.  Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.

[15]  D. Cockayne,et al.  Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. E. Anderson,et al.  Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. , 2001, Protein engineering.

[17]  K. Takegoshi,et al.  Indirect high-resolution observation of 14N NMR in rotating solids. , 2001, Journal of the American Chemical Society.

[18]  B. Fung,et al.  An improved broadband decoupling sequence for liquid crystals and solids. , 2000, Journal of magnetic resonance.

[19]  A. Yamashita,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[20]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[21]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.